EUVIMEDEUVIMED entdecken
Open Access

Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer

Pia Banerjee, Nicholas S Phillips iD, Wei Liu, Matthew J Ehrhardt, Nickhill Bhakta, Tara M Brinkman, Annalynn M Williams, Yutaka Yasui iD, Raja B Khan, Deokumar Srivastava, Kirsten K Ness, Leslie L Robison und 2 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Pia Banerjee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Phenotype, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Lebanese-Syrian Associated Charities, NCI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurocognitive impairments are sequelae of childhood cancer treatment, however little guidance is given to clinicians on common phenotypes of impairment or modifiable risk factors that could lead to personalized interventions in survivorship.

Methods

Standardized clinical testing of neurocognitive function was conducted in 2958 (74.1%) eligible survivors, who were at least 5 years postdiagnosis and aged older than 18 years, and 477 community controls. Impairment was examined across 20 measures, and phenotypes were determined by latent class analysis. Multinomial logistic regression was used to estimate risk for phenotype, predicted by cancer diagnosis and treatment exposures, chronic health conditions, and lifestyle, adjusted for sex and age. Associations between phenotypes and social attainment were examined.

Results

Five neurocognitive phenotypes were identified in survivors (global impairment 3.7%, impaired attention 5.0%, memory impairment 7.2%, processing speed and executive function impairment 9.3%, no impairment 74.8%). Risk of global impairment was associated with severe chronic health condition burden (odds ratio [OR] = 20.17, 95% confidence interval [CI] = 11.41 to 35.63) including cerebrovascular disease (OR = 14.5, 95% CI = 5.47 to 38.44) and cerebrovascular accident (OR = 14.7, 95% CI = 7.50 to 26.40). Modifiable risk factors, such as quitting smoking, reduced risk for global impairment (OR = 0.21, 95% CI = 0.06 to 0.66). Low physical activity increased risk for global impairment (OR = 4.54, 95% CI = 2.86 to 7.21), attention impairment (OR = 2.01, 95% CI = 1.41 to 2.87), processing speed and executive function impairment (OR = 1.90, 95% CI = 1.46 to 2.48), and memory impairment (OR = 2.09, 95% CI = 1.54 to 2.82).

Conclusions

Results support the clinical utility of neurocognitive phenotyping to develop risk profiles and personalized clinical interventions, such as preventing cerebrovascular disease in anthracycline-treated survivors by preventing hypercholesterolemia, smoking, and sedentary lifestyle, to reduce the risk for global impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsPhenotypeNeoplasmsHumansMaleFemaleAdultRisk FactorsYoung AdultAdolescentNeuropsychological TestsMiddle AgedNeurocognitive DisordersChildCognitive Dysfunction

Autor:innen und Institutionen

  • Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Psychology and Biobehavioral Science, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Pediatric Medicine, Division of Neurology, St Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Nicholas S Phillips, Yutaka Yasui

Förderung

  • American Lebanese-Syrian Associated Charities
  • NCI NIH HHS
  • National Institute of Health
  • National Cancer Institute

Zitieren

APA

Banerjee, P., Phillips, N. S., Liu, W., Ehrhardt, M. J., Bhakta, N., Brinkman, T. M., Williams, A. M., Yasui, Y., Khan, R. B., Srivastava, D., Ness, K. K., Robison, L. L., Hudson, M. M., & Krull, K. R. (2024). Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae149

Vancouver

Banerjee P, Phillips NS, Liu W, Ehrhardt MJ, Bhakta N, Brinkman TM, et al. Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae149

BibTeX
@article{Banerjee2024,
  author = {Banerjee, Pia and Phillips, Nicholas S and Liu, Wei and Ehrhardt, Matthew J and Bhakta, Nickhill and Brinkman, Tara M and Williams, Annalynn M and Yasui, Yutaka and Khan, Raja B and Srivastava, Deokumar and Ness, Kirsten K and Robison, Leslie L and Hudson, Melissa M and Krull, Kevin R},
  title = {Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae149}
}
Kostenlos starten →